Medicinova (MNOV) Receives Nortice of Allowance from EPO for MN-029 Patent
Tweet Send to a Friend
MediciNova, Inc.,(Nasdaq: MNOV) announced receipt from the European Patent Office of a notice of intent to allow patent for MN-029 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE